KDM4B: A promising oncology therapeutic target
Cancer Science · 2024-01 · 115 (1) · 8-16
DOI: 10.1111/cas.16005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 03.11.2023. Verfasst von Fangjing Ni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Epigenetic modifications are significant in tumor pathogenesis, wherein the process of histone demethylation is indispensable for regulating gene transcription, apoptosis, DNA replication, and repair of damaged DNA. The lysine demethylases (KDMs) serve an essential role in the aforementioned processes, with particular emphasis on the KDM4 family, also referred to as JMJD2. Multiple studies have underscored the significance of the KDM4 family in the regulation of various biological processes including, but not limited to, the cell cycle, DNA repair mechanisms, signaling pathways, and the progression of tumor formation. Nevertheless, it is imperative to elucidate the underlying mechanism of KDM4B, which belongs to the KDM4 gene family. This review presents a comprehensive examination of the structure, mechanism, and function of KDM4B, as well as a critical analysis of the current body of research pertaining to its involvement in tumorigenesis and development. Furthermore, this review explores the potential therapeutic strategies that specifically target KDM4B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Xiang Wang
Zitieren
APA
Ni, F., Tang, H., Cheng, S., Yu, Y., Yuan, Z., Chen, Y., Zhang, E., & Wang, X. (2024). KDM4B: A promising oncology therapeutic target. Cancer Science, 115(1), 8-16. https://doi.org/10.1111/cas.16005
Vancouver
Ni F, Tang H, Cheng S, Yu Y, Yuan Z, Chen Y, et al. KDM4B: A promising oncology therapeutic target. Cancer Science. 2024;115(1):8-16. doi:10.1111/cas.16005
BibTeX
@article{Ni2024,
author = {Ni, Fangjing and Tang, Heting and Cheng, Siteng and Yu, Yaoyu and Yuan, Zhihao and Chen, Yingfei and Zhang, Encheng and Wang, Xiang},
title = {KDM4B: A promising oncology therapeutic target},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {1},
pages = {8--16},
doi = {10.1111/cas.16005}
}
EUVIMED